These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12922968)

  • 1. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria.
    Valentini G; Bencivelli W; Bombardieri S; D'Angelo S; Della Rossa A; Silman AJ; Black CM; Czirjak L; Nielsen H; Vlachoyiannopoulos PG
    Ann Rheum Dis; 2003 Sep; 62(9):901-3. PubMed ID: 12922968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.
    Valentini G; Iudici M; Walker UA; Jaeger VK; Baron M; Carreira P; Czirják L; Denton CP; Distler O; Hachulla E; Herrick AL; Kowal-Bielecka O; Pope J; Müller-Ladner U; Riemekasten G; Avouac J; Frerix M; Jordan S; Minier T; Siegert E; Ong VH; Vettori S; Allanore Y
    Ann Rheum Dis; 2017 Jan; 76(1):270-276. PubMed ID: 27621285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.
    Valentini G; Della Rossa A; Bombardieri S; Bencivelli W; Silman AJ; D'Angelo S; Cerinic MM; Belch JF; Black CM; Bruhlmann P; Czirják L; De Luca A; Drosos AA; Ferri C; Gabrielli A; Giacomelli R; Hayem G; Inanc M; McHugh NJ; Nielsen H; Rosada M; Scorza R; Stork J; Sysa A; van den Hoogen FH; Vlachoyiannopoulos PJ
    Ann Rheum Dis; 2001 Jun; 60(6):592-8. PubMed ID: 11350848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
    Nevskaya T; Baron M; Pope JE;
    Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the 2017 EUSTAR activity index in an scleroderma cohort.
    Ross L; Stevens W; Wilson M; Huq M; Strickland G; Walker J; Sahhar J; Ngian GS; Roddy J; Youssef P; Proudman S; Nikpour M
    Clin Rheumatol; 2020 Dec; 39(12):3701-3705. PubMed ID: 32696281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of disease activity indices using the 28 joint counts in systemic sclerosis.
    Lóránd V; Bálint Z; Komjáti D; Németh B; Minier T; Kumánovics G; Farkas N; Czirják L; Varjú C;
    Rheumatology (Oxford); 2016 Oct; 55(10):1849-58. PubMed ID: 27402873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do We Have Good Activity Indices in Systemic Sclerosis?
    Groseanu L; Petrescu S; Balanescu A; Bojinca V; Opris-Belinski D; Berghea F; Mazilu D; Saulescu I; Borangiu A; Daia-Iliescu S; Constantinescu C; Cobilinschi C; Abobului M; Negru MM; Ionescu R
    Curr Rheumatol Rev; 2022; 18(1):39-47. PubMed ID: 34517805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity.
    Pignataro F; Maglione W; Minniti A; Sambataro D; Sambataro G; Campanaro F; Valentini G; Vitali C; Del Papa N
    Arthritis Res Ther; 2019 Nov; 21(1):258. PubMed ID: 31783890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease activity indices in systemic sclerosis: a systematic literature review.
    Melsens K; De Keyser F; Decuman S; Piette Y; Vandecasteele E; Smith V
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):186-192. PubMed ID: 27385265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis.
    Hesselstrand R; Nilsson JÅ; Sandqvist G
    Scand J Rheumatol; 2013; 42(4):317-24. PubMed ID: 23442162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary disease severity score for juvenile systemic sclerosis.
    La Torre F; Martini G; Russo R; Katsicas MM; Corona F; Calcagno G; Falcini F; Vittadello F; Zulian F
    Arthritis Rheum; 2012 Dec; 64(12):4143-50. PubMed ID: 22886849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis.
    Minier T; Nagy Z; Bálint Z; Farkas H; Radics J; Kumánovics G; Czömpöly T; Simon D; Varjú C; Németh P; Czirják L
    Rheumatology (Oxford); 2010 Jun; 49(6):1133-45. PubMed ID: 20236952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of disease activity.
    Valentini G; Silman AJ; Veale D
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S39-41. PubMed ID: 12889221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a modified hand mobility in scleroderma (HAMIS) test and its potential as an outcome measure in systemic sclerosis.
    Sandqvist G; Nilsson JÅ; Wuttge DM; Hesselstrand R
    J Rheumatol; 2014 Nov; 41(11):2186-92. PubMed ID: 25274889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.